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COVID-19: Perspectives for the 
management of dental care and 
education
The rapid and abrupt transmission pattern of the SARS-CoV-2 unleashed 
the current COVID-19 pandemic, as recognized by the World Health 
Organization in March 2020. Considering the high risk of transmission of 
the virus in dental environments and the specificities in clinical practice, 
COVID-19 posed immediate challenges for dental care and education. Due 
to the need to establish infection prevention and control guidance in dental 
health settings to enable a safe clinical practice, this review aims to list 
the challenges and perspectives in managing dental care in services and 
schools. This review employed materials collected from PubMed and the main 
guidelines and studies on the novel coronavirus to provide an overview of the 
clinical procedures and decisions made by health care personnel in dental 
offices and dental schools. We expect the COVID-19 scenario to promote 
significant changes in clinical practice and dental education; dentists should 
seek specific and particular regulations for dental practice established by 
their state or country. Biosafety checklists are strongly recommended for 
appointments at dental services and face-to-face activities in dental schools.
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Introduction
SARS-CoV-2 is a contagious RNA virus that causes 
the coronavirus disease 2019 (COVID-19) in the 
human population. This novel coronavirus is thought 
to spread primarily through respiratory droplets and 
fomites, but airborne transmission from person-to-
person over long distances is unlikely.3 The virus can 
survive in aerosols for hours and on surfaces up to 
days.4,5 Pre-symptomatic or asymptomatic patients 
can also spread the virus, facilitating the transmission 
process.4,6-8
In December 2019, COVID-19 was first diagnosed 
in a human and recognized as a serious respiratory 
disease in Wuhan city, Hubei province, in China. 
Since then, a huge scientific task force has been 
assembled to collect information about the disease.9 
Several studies have been developed to identify its 
biological mechanism, infectious agent, contagion and 
transmission modes, diagnostic tests, and to search 
drugs and vaccines to tackle the virus.
Due to the rapid and abrupt worldwide transmission 
pattern of the COVID-19, in March 2020 the 
World Health Organization declared the outbreak a 
pandemic.10 Despite global efforts to stem the spread 
of the disease, the incidence rate of COVID-19 is 
continuously increasing: the latest issue reported over 
29,155,581 laboratory-confirmed cases and more than 
926,544 deaths worldwide.11
During this novel coronavirus pandemic, several 
countries have adopted restrictive measures and 
actions to decrease close contact among people, 
for preventing the spread of the virus and limiting 
contagion (social isolation and self-quarantine). Such 
measures pose immediate challenges for dental 
health care personnel (DHCP) and dental education 
institutions of all affected regions.
Current Scenario
A Chinese team of scientists quickly isolated the 
virus from patients and sequenced its genome (29,903 
nucleotides). They verified that although SARS-CoV-2 
is different from SARS-CoV – which causes the Severe 
Acute Respiratory Syndrome (SARS) identified in 
2003 in China – they share the same host receptor, 
human angiotensin-converting enzyme 2 (ACE2).12 In 
other words, SARS-CoV-2 can effectively use ACE2 
as a receptor to invade humans cells, facilitating 
transmission.4
ACE2 receptors on epithelial cells of the oral 
mucosa and on gland ducts showed to be early targets 
of SARS-CoV infection13 and possibly of SARS-CoV-2. 
This, along with other evidence, highlights the hidden 
capability of saliva for the early detection of various 
viral, bacterial, or systemic diseases (Epstein-Barr 
virus - EBV; Cytomegaloviruses - CMV; Varicella-Zoster 
virus - VZV, Human papillomavirus - HPV).14
Scientists isolated the novel coronavirus from 
COVID-19 patients saliva, which could become a major 
source of viral load.15 Considering that, both DHCP 
and patients are at infection risk by routine dental 
practices that enable contact with mucous membranes, 
microorganisms, large drops of water, saliva, blood 
(among other body fluids), and with debris thrown into 
the air due to the use of air-water syringes, rotatory 
instruments, or ultrasonic scalers,.4,16 The high ACE2 
expression in salivary glands makes this protein a 
potential target for COVID-19.17 Moreover, SARS-
CoV RNA can be reportedly detected in saliva before 
lung lesions appear,18 indicating that asymptomatic 
COVID-19 spread may derive from infected saliva.17
A recent study proved the consistent presence of 
SARS-CoV-2 in the saliva of 11 patients admitted for 
COVID-19 infection from the first day of hospitalization 
in a Hong Kong hospital.15 Material was collected by 
instructing patients to cough saliva from their throat 
into a sterile container and referred to laboratory 
analysis. This study results demonstrate the potential 
use of saliva in developing more convenient tests and 
in early detecting COVID-19.14 When compared to the 
currently recommended respiratory samples, such 
as the nasopharyngeal and oropharyngeal smears,19 
collecting saliva is technically easier and more 
comfortable to the patient, so it should be explored 
in the current pandemic scenario. Using saliva to 
diagnose COVID-19 is safer for health care providers 
and could expand testing capacities worldwide. 
Telemedicine has granted electronic consultations 
even more visibility during this COVID-19 pandemic.20 
Such approach allows patients screening and 
avoids spreading the virus among patients, health 
professionals, and the community.21 Although recent 
evidence support the adoption of teledentistry,22,23 
conclusive study outcomes are not sufficient to 
evaluate the efficacy, cost-effectiveness, and long-
term use of this approach and support evidence-based 
policy decisions23 in private or public services. 
Teledentristy is feasible for some areas in 
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dentistry in providing remote consultations for 
developing treatment plans, promoting preventive 
care, and supervising home procedures such as 
pediatric dentistry, oral medicine, orthodontics, 
prosthodontics, periodontics, and restorative dentistry. 
A recent systematic review found telediagnosis and 
teleconsultation to be the most common applications, 
grounded on store-and-forward technology and real-
time encounters.23 A future perspective is improving 
and developing technology to provide access to 
teledentistry and extend the service in several 
countries.
A study published on April 19, 2020 reveals the 
progress and challenges in developing drugs to tackle 
COVID-19, with some updates.9 Although no specific 
drug is currently suitable for treating COVID-19, 
this study lists some medication and alternative 
treatments, such as favilair, remdesivir, chloroquine, 
and hydroxychloroquine.9 In an attempt of developing 
a method to confer acquired immunity against the 
disease, several SARS-CoV-2 vaccine prototypes have 
been developed and tested by countries around the 
world. Canada, China, United Kingdom, Russia, Brazil, 
and United States have been working to develop a 
vaccine in a short time. It is estimated that it will take 
at least one year, after pre-clinical and clinical studies, 
to make vaccine available to the population.9 Producing 
and testing these products will demand high costs for 
the governments.
According to Alharbi, Alharbi, and Alqaidi24 (2020), 
suspending dental practices during the course of 
the novel coronavirus pandemic may contribute to 
reducing infection, but will increase the suffering of 
individuals requiring emergency dental care.24 Such 
measure may also contribute in overcrowding hospital 
emergency departments, evincing great importance in 
providing dental care, even during a global pandemic. 
Some countries are gradually reopening their economic 
activities, including dental practices. In this scenario, 
it is necessary to establish infection prevention and 
control guidance in dental health settings to enable 
a safe clinical practice (both in dental offices and 
schools), during and after the pandemic. 
Dental education is being dramatically impacted 
due to the higher risk of contamination of patients, 
teaching staff, students, and DHCP, as these 
individuals circulate in an environment that favors 
virus spreading. As an example, the number of 
cases among health care professionals (especially 
physicians), nurses, and dentists is high.4,9,16 This 
review aims to list the challenges and perspectives in 
managing dental care and education during and after 
the course of the COVID-19 pandemic. 
This is not a systematic review. This manuscript 
was written based on material collected from 
the PubMed database, using the search terms: 
“coronavirus”, “SARS-CoV-2”, “COVID-19”, “dentistry”, 
“dental”, “oral cavity”, “biofilm”, “saliva”, “dental public 
health”, “infection control”, “prevention”, “education”, 
and “practice management;” the search was limited 
to texts written in English. 
Infection prevention and control for dental 
practice 
Dental professionals should be prepared to identify 
patients with COVID-19 and to take extra-protective 
measures required during clinical practice to prevent 
the transmission.4 We will present infection prevention 
and control measures indicated for these professionals 
before, during, and after dental procedures implicating 
a possible droplet and aerosol transmission of 
COVID-19, most important concerns in dental offices. 
The presented recommendations are based on the 
guidance for healthcare workers,19 for infection 
prevention and control during healthcare when 
COVID-19 is suspected,25 and the American Dental 
Association (ADA) interim guidance for minimizing 
risk of COVID-19 transmission.26
The ADA proposed three algorithms serving as 
interim guidance to assist dentists and dental offices 
in making informed decisions concerning patient 
triage, evaluation, and treatment during the COVID-19 
pandemic: (1) triaging patients for emergency and 
urgent dental care, (2) screening to identify COVID-19 
infection in emergency and urgent dental patients, 
to determine whether patients can be treated at the 
dental office (3) and assessing patients’ risk during 
the pandemic.27 The guidance also recommends dental 
offices and schools to take actions for preventing and 
controlling the infection.
Before the dental procedure 
Initially, dental health care personnel (DHCP) 
must prepare the dental team.26 DHCP should have 
received influenza vaccination and professionals 
presenting influenza-like illness (ILI) (fever, cough, 
sore throat, muscle pain) should avoid showing up 
to work. All DHCP must self-monitor by observing 
possible respiratory symptoms (cough, shortness of 
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breath, sore throat) and check their temperatures 
twice a day. Officers must control the available 
personal protective equipment (PPE - surgical masks, 
surgical gowns, surgical gloves, face shields) supplies. 
Appointments should be scheduled far enough apart 
to minimize possible contact with other patients in 
the waiting room. Patients should be requested not to 
take companions to their appointments, except when 
they require assistance (pediatric patients, people with 
special needs, older adults).
Then, personnel must screen patients for COVID-19 
status and triage them for dental treatment, providing 
early recognition and source control (isolating patients 
with suspected COVID-19).26,28 Patient’s interview 
should preferably be conducted by telephone, text 
and images messaging mobile applications, or 
video conference, which can be useful with instant 
communication and quick decisions before the 
visit.21,23 The ADA also recommends dentists to apply 
a screening questionnaire with appropriate questions 
to track suspected COVID-19 patients. Questions may 
address whether, in the last 14 days, the patient has 
been in close contact with people diagnosed or under 
investigation for COVID-19 or has had fever, sore 
throat, cough, or shortness of breath. Screening should 
be performed at appointment confirmation, 24 hours 
before, or when the patient presents for treatment.26
Public areas and clinical environments must be 
properly and rigorously cleaned and disinfected. 
Thoroughly cleaning environmental surfaces with water 
and detergent and applying high-level disinfectants 
(such as 3% sodium hypochlorite) are effective and 
sufficient procedures.25 Medical devices/equipment and 
utensils, including knobs, chairs and tables, should be 
cleaned frequently following safe routine procedures.
Upon patient arrival, the waiting room should allow 
a social distance of at least 2 meters between people.27 
Consultations must be scheduled by appointment to 
avoid overcrowding. The service must provide supplies 
to maintain hygiene/breathing level by offering a 
medical mask to patients while they wait and asking 
them to perform hand hygiene (cleaning hands with 
70% alcohol for 20 to 30 s, or with soap and water 
from 40 to 60 s).25
Professionals should perform another screening 
to confirm patients’ health condition by checking 
their temperature, preferably using a non-contact 
forehead thermometer or infrared cameras. If the 
patient exhibits a temperature higher than 37.5oC 
or signs of respiratory diseases, dental care must be 
postponed for 14 days and patients must follow the 
recommendations previously listed.29,30 
No clinical study supported using mouthrinse 
before dental procedures, nor any specific mouthrinse 
virucidal efficacy against SARS-CoV-2.31 Although 
chlorhexidine is considered the gold standard for oral 
antiseptics, according to the Chinese Clinical Guidelines 
for COVID-19 pneumonia diagnosis and treatment (5th 
edition) published by the National Health Commission 
of the People’s Republic of China, it may not be 
effective in killing SARS-CoV-2.4,31 As SARS-CoV-2 
may be vulnerable to oxidation, the ADA suggests 
using mouthrinse with 1.5% hydrogen peroxide or 
0.2% povidone prior to conducting procedures,26 as 
well as 0.05% to 0.1% cetylpyridinium chloride, which 
seems to provide additional protection against upper 
respiratory infections.32
During the dental procedure
During dental procedures, standard precautions 
include preparing all instruments, performing 
hand/respiratory hygiene, using adequate PPE and 
disposable covers for total protection.8 According 
to Peng, et al.4 (2020, adapted according to WHO8 
guidelines), three-level protective measures of DHCP 
are recommended for specific situations:4 (1) Primary 
protection (standard protection for staff in clinical 
settings), which consists of wearing disposable working 
cap, disposable surgical mask, working coat, protective 
goggles or face shield, and disposable latex or nitrile 
gloves; (2) Secondary protection (advanced protection 
for dental professionals), wearing a disposable doctor 
cap and surgical mask, protective goggles, face 
shield, and working clothes with disposable isolation 
clothing, and disposable latex gloves; and (3) Tertiary 
protection (strengthened protection for contact 
with suspected or confirmed COVID-19 patient), all 
secondary-protection level added to disposable N95 
masks and impermeable shoe covers.
Dental care should be fast and as minimally 
invasive as possible, avoiding aerosol-generating 
procedures. Dental care environment should employ 
high-efficiency particulate arresting (HEPA) air 
purifiers to ensure DHCP and patients safety (Chen 
and Zhao, 2020). For biosafety control, all filters must 
be replaced and disposed of in regular intervals.33 To 
minimize the risk of cross-infection, dentists should 
use single-use devices, such as disposable air/water 
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syringe tips, disposable handpieces, and plastic 
wraps for all exposed surfaces27. Services should 
limit complementary exams, as intraoral images, 
and perform extraoral radiographs to avoid increased 
salivary flow rate and pharyngeal reflex, often caused 
during intraoral imaging.4,24
Whenever possible, procedures should employ a 
rubber dam, to reduce aerosols and microorganisms 
spread,26,27,34 and a four-handed operation, regardless 
of the rubber dam. Extra high-volume suction devices 
should be used in conjunction with regular suction 
for aerosols, fomites and saliva.4,27,34 When rubber 
dam use is unfeasible, manual devices for removing 
dental cavities and performing periodontal treatment 
are recommended to minimize aerosol production 
as much as possible.4,27 During procedures, patients 
should wear a protective coat, disposable working cap, 
and protective goggles.
Patients with suspected or confirmed COVID-19 
must be attended only for emergency treatment 
and instructed to wear a disposable surgical mask. 
Appointments should be scheduled far enough apart 
to avoid possible contact with other individuals. 
Treatment should be preferably performed in a 
negative pressure/air borne precaution room.29
After the dental procedure 
According to the ADA, after dental appointment 
completion, professionals should reinforce instructions 
on social distance and infection control etiquette 
(hand and respiratory hygiene).26 Special attention 
must be paid to cleaning and disinfecting dental 
office, reusable PPE (goggles and facial shields), 
and non-disposable and non-sterilizable equipment 
(dental x-ray equipment, dental chair and light). Other 
instruments that go into direct contact with fluids and 
the oral cavity must be sterilized in an autoclave. Oral 
hygiene care should be reinforced during this period.
Professionals with symptoms or suspected 
COVID-19 
Professionals exhibiting symptoms or those 
suspected of COVID-19 (after being exposed to a 
confirmed COVID-19 patient) must discontinue all 
healthcare interactions for a 14-day period,19 tested for 
COVID-19, and quarantined for 14 days.25 If test result 
comes out positive, patients attended in the previous 
week and DCHP working with the professional must 
be notified, instructed to self-quarantine at home for 
7 days, and report any fever or influenza-like illness 
experience to local health services.
Dental education 
Worldwide, most dental schools suspended 
teaching activity due to pandemic spread to reduce 
virus transmission and the spread of COVID-19 in 
dental departments. As a consequence, this strategy 
has exerted numerous effects on dental education, 
such as: interrupting face-to-face instruction, including 
pre-clinical and clinical activities; interrupting patients’ 
assistance; discontinuing development of human 
and some animal studies, especially in postgraduate 
programs; cancelling scientific congresses and 
conferences; abruptly changing academic calendars, 
including extra semesters; and postponing graduation 
ceremonies and new students entry.35,36 We should also 
consider the negative impact on the mental health of 
professionals, professors, and students.36,37,38 
Considering that, a major concern among dental 
schools is restarting activities. As dental schools cannot 
extensively adopt web-based teaching for practicing, 
some urgent considerations are necessary.38,39,40 
Resuming dental schools activities in classroom 
and clinics depends on the course of this pandemic 
in each country and specific field. Currently, some 
dental schools have resumed or prepared to reopen 
after government decisions,40 what urges for some 
recommendations on how to organize dental education 
considering the “new normal” in Dentistry.
Education
The pandemic forced many dental schools to 
temporarily adapt to a fully-virtual curriculum. To 
accommodate the lasting effects of COVID-19, some 
strategies adopted for distance education should be 
maintained in a hybrid-teaching format in the upcoming 
months.35,38 Considering that, institutions should use 
remote strategies, such as free digital platforms 
and software – mediated synchronously (live) and 
asynchronously (recordings),37,41 – videoconferences, 
online forums and lectures, critical review of scientific 
articles, clinical cases discussion, problem-based 
learning tutorials, and demonstrations of laboratory 
and clinical techniques, to avoid unnecessary 
agglomerations.37,38,41,42 These technology-mediated 
pedagogical approaches can help creating an active 
learning environment and cultivate positive attitudes 
towards the teaching-learning process among 
dentistry students.39,41,42
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Preclinical practice
Schools should also encourage preclinical activities 
in the simulation laboratory using mannequins, given 
the possible reduced availability of clinical practice 
with patients, especially for first-year students of 
graduation courses.35,37 Another alternative is the use 
of digital strategies, by software capable of creating 
and reproducing virtual three-dimensional models that 
can be accessed by computers and mobile devices. 
Such approaches may enable students to learn 
techniques and concepts applied into different dental 
specialties.43,44,45 However, remote strategies should 
not replace clinical practice with patients in acquiring 
abilities inherent to the dental training.
Clinical practice
As dental school environment aggravates 
agglomeration, some prevention strategies should 
be implemented to reduce contamination among 
those individuals before dental treatment (at-home 
patients and those entering the dental school). Patients 
should undergo screening, to investigate their health 
conditions and suspected cases of COVID-19,42  by 
telephone, 24 hours before consultation, or at first-
contact for the appointment, as soon as the patient 
arrives at the dental school. Patients with difficulty 
in explaining their oral problem by telephone must 
receive consultation by video. Those suspected of 
COVID-19 must be referred to another local health 
service.42
When patients arrive at the dental school, 
practitioners must register their body temperature 
and apply a current health status questionnaire to 
avoid cross-infection during appointment.19 Patients 
presenting risk factors (advanced age and other 
comorbidities) should have their appointments 
postponed as far as possible, or be treated in a remote 
area.
Visible recommendations should be available 
outside the dental school, instructing patients on 
hygiene and respiratory etiquette. The school is 
recommended to strictly control the number of patients 
in the waiting room and display chairs within a 2-meter 
distance. Patients should only take companions into 
the clinic if necessary,16 and are advised to leave all 
belongings outside. 
Students should provide all necessary materials 
before the dental procedure to limit contact with other 
students and personnel and to perform the procedure 
as fast as possible. Special care must be taken 
with shared dental consumables. Since procedures 
become more complex as the graduation course 
advances, dental students generally take longer to 
perform procedures, especially at clinical-stage, in the 
beginning of the course. The risk of cross-infection is 
higher at this stage because students spend more time 
in contact with the patient, depending on the nature 
of the procedure to be performed.
Four-hand work is extremely necessary during 
dental procedures to prevent contagion and speed up 
the appointment. Hand hygiene should be rigorously 
performed at each appointment and PPE should be 
available for all dental practitioners. Before dental 
treatment, prescribing mouthrinses is recommended – 
rinses should contain 1% hydrogen peroxide, or 0.2% 
to 1% povidone, or 0.05% to 0.1% cetylpyridinium 
chloride agents, and are particularly indicated when 
a rubber dam is not used.16,32 Students should opt for 
procedures that produce no or little aerosol and for 
using manual instruments when possible. Patients 
must wear a protective coat, disposable working cap, 
and protective goggles during procedures.
After completion, all potentially contaminated 
surfaces should be cleaned. Sterilizable instruments 
should be disinfected using enzymatic detergents, 
which is effective in removing organic matter and 
rapidly decomposing adhered blood and body fluids. 
Other dental settings should be cleaned with 70% 
alcohol. Surfaces should be disinfected with 0.1% 
sodium hypochlorite and 70% alcohol.16 
After each practical assistance, disposable PPE 
should be discarded and the rest of the equipment 
disinfected. As the virus remains alive in droplets 
suspended in the air, PPE should not be removed 
before exiting the area,16 and during removal 
touching any external part of the equipment must be 
avoided, including disposable masks and caps. For a 
safer practice, the dental team should be constantly 
monitored by rapid diagnostic tests for COVID-19.39 
Regarding infection control measures, Emami36 
(2020) argues that dental teams are familiar in 
treating patients with infectious diseases (hepatitis, 
HIV) and routinely working with strict environmental 
control  and PPE. As an example, a recent multinational 
study approaching dentists’ knowledge, attitudes, and 
practices regarding COVID-19 revealed that 92.7% 
of the participants presented high/good knowledge 
and 79.5% high/good care practices, evincing these 
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professionals promising role in controlling COVID-19 
infections.46 Choi and Kim47 (2016) investigated factors 
influencing the prevention of the MERS-CoV by applying 
a questionnaire to nursing students, and found that 
attitude was the most affected preventive behavior. 
Perceived risk, older students, education level during 
graduation course, and female respondents were also 
associated with a higher perception.
Park, et al.48 (2016) reported a medical school 
experience during a Middle East Respiratory Syndrome 
(MERS) outbreak and suggested schools to consider 
distant education with online technology, distant 
lectures, and tutorials. Key decisions to avoid student 
infection were based on (1) student safety, (2) 
minimizing learning loss, and (3) reducing students 
and staff anxiety and concern. The medical school 
assessed ongoing risk and developed contingency 
plans to balance staff and student safety and created 
a monitoring team. It also adopted precautions, such 
as repeated hand washing and sanitizing, taking 
temperatures twice a day, and wearing masks. 
Bulletin boards, emails, and text messages included 
reminders and recommended precautions in case of 
initial symptoms of MERS.48
Dental schools will eventually reopen according 
to government schedules. However, school staff 
must develop an strategic plan to avoid any learning 
loss from students and reduce the risk of COVID-19 
infection among patients, lecturers, students, and 
other staff. Adopting such strategies in the daily life 
of dental schools will strengthen dental education now 
and in future unexpected crisis.
Perspectives for Future Research
The COVID-19 pandemic has urged scientific 
researchers and nanotechnology experts to study and 
develop devices capable of performing diagnosis and 
therapy. Mesenchymal stem cells (MSCs) showed good 
results in the treatment of patients with COVID-19 
pneumonia, probably by preventing or reversing 
pro-inflammatory cytokines overactivation, allowing 
tissue repair and maintaining mortality as low as 
possible.49,50,51 Widely addressed in regenerative 
medicine and dentistry, MSCs demonstrated a valuable 
potential clinical application due to their repairing 
behavior and immunomodulatory properties.52,53 In 
this context, Dentistry is outlined for developing future 
research and therapies involving MSCs, as sources are 
easily accessible and of low biological cost and risk.53
 The theranostic approach54 could also be advanced 
to manage some diseases using nanomaterials – that 
is, as a drugs carriers for specific action in tissues 
or cells using nanobiotechnology and translational 
research. Due to its predictability, preventive, 
personal, and participatory potential,54,55 theranostics 
promises to increase clinical performance (including in 
Dentistry), reducing costs and helping identifying the 
ideal and individualized treatment for each patient, at 
the right moment, in an analysis beyond the current 
pandemic scenario.
Conclusion
Dental professionals must be prepared to face 
any imminent challenge in clinical practice imposed 
by infectious diseases, e.g. COVID-19, and define a 
conduct for patient care, by postponing consultations 
and referring individuals to quarantine at home or 
to healthcare centers and hospitals. Dentist role in 
preventing and monitoring viral infections should be 
constantly reviewed. Following prevention guidelines 
proposed by the WHO is important to prevent SARS-
CoV-2 action in the population until drugs and vaccines 
are developed.
Dentists should seek specific regulations for dental 
care established by their state or country regarding 
the COVID-19 pandemic. Biosafety checklists 
should also be consulted for managing protective 
personal equipment, dental settings and devices, and 
surrounding spaces – as those used before, during, 
and after dental appointments. As significant changes 
are expected in clinical practice and dental schools, 
individuals should seek further and rapid information 
to handle and improve this issue.
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